98%
921
2 minutes
20
Background: Gay and bisexual men (GBM) who use HIV preexposure prophylaxis (HIV-PrEP) have high rates of bacterial sexually transmitted infections (STIs). The use of daily antibiotics as STI preexposure prophylaxis (STI-PrEP) may be appealing to GBM who are using or have previously used HIV-PrEP (HIV-PrEP-experienced) for the prevention of bacterial STIs.
Methods: We examined willingness to use daily STI-PrEP among a cross-sectional sample of HIV-PrEP-experienced GBM in Australia who participated in an observational online cohort study from August 2018 to March 2020. Factors associated with willingness to use daily STI-PrEP were determined using bivariate and multivariate logistic regression.
Results: Of the 1347 participants, half (54.3%) were willing to use daily STI-PrEP. Factors independently associated with greater willingness to use daily STI-PrEP included having >10 sexual partners in the last 6 months, using methamphetamine in the last 6 months, being more conscious about avoiding STIs, having a greater number of STIs since commencing HIV-PrEP, being willing to take HIV-PrEP for as long as they were at risk of acquiring HIV, and only using condoms when a sexual partner requested them. Conversely, factors associated with less willingness to use daily STI-PrEP included being university educated, using nondaily dosing regimens of HIV-PrEP, preferring event-driven HIV-PrEP, and being concerned about long-term HIV-PrEP adverse effects.
Conclusions: Sexually transmitted infection PrEP is likely to be appealing to many HIV-PrEP-experienced GBM, especially those who engage in activities associated with a higher risk of STI transmission. However, they are less likely to be willing to use STI-PrEP unless it aligns with their HIV-PrEP dosing regimen, suggesting that research into the safety and efficacy of alternative STI prophylaxis dosing options should be prioritized.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/OLQ.0000000000001731 | DOI Listing |
Glob Health Action
December 2025
Department of Speech-language Pathology and Audiology, University of Pretoria, Pretoria, South Africa.
Background: Hearing loss affects more than 1.5 billion people worldwide, yet fewer than 10% of those who could benefit from hearing aids are able to access them. Barriers such as high costs, limited availability, and a critical shortage of trained professionals in low- and middle-income countries contribute to this gap, while emerging models of care-such as task-shifting to community healthcare workers (CHWs) supported by mHealth technologies-show promise in improving access, affordability, and outcomes in underserved communities.
View Article and Find Full Text PDFDiabetes Ther
September 2025
RTI Health Solutions, Durham, NC, USA.
Introduction: Novel therapies, including disease-modifying and cell replacement therapies, may preserve or replace beta cells in people with type 1 diabetes. This study sought to understand how people living with type 1 diabetes or caring for someone with type 1 diabetes perceive the benefits and risks of novel therapies.
Methods: Semistructured qualitative interviews were conducted with 26 participants in the United States: four adolescents and 12 adults with type 1 diabetes, and 10 caregivers of children with type 1 diabetes.
JMIR Mhealth Uhealth
September 2025
Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, 401 Park Drive, Suite 401 East, Boston, MA, 02215, United States.
Background: Intensive measures of well-being and behaviors in large epidemiologic cohorts have the potential to enhance health research in these areas. Yet, little is known regarding the feasibility of using mobile technology to collect intensive data in the "natural" environment in the context of ongoing large cohort studies.
Objective: We examined the feasibility of using smartphone digital phenotyping to collect highly resolved psychological and behavioral data from participants in a pilot study with participants in Nurses' Health Study II, a nationwide prospective cohort of women.
Front Psychiatry
August 2025
Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Background: Autism Spectrum Disorder (ASD) is characterized by social deficits and restricted, repetitive behaviors, with fewer than 10% achieving independent adulthood. Immersive virtual reality (IVR) provides a novel training approach through interactive and realistic environments. This study developed an IVR system to enhance adaptive skills in children and adolescents with high-functioning ASD.
View Article and Find Full Text PDFBMC Musculoskelet Disord
September 2025
Department of People and Technology, Roskilde University, Universitetsvej 1, 4000, Roskilde, Denmark.
Background: Knee arthroplasty is a common surgical treatment aimed at improving function and reducing pain. While generally successful, some patients experience complications or dissatisfaction, leading to a sequence of revision surgeries. These revisions are less successful than primary surgeries and carry risks.
View Article and Find Full Text PDF